ELIZABETH GATTMAN: Open Payments
NPI 1831620152 · JAMESTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,857 in 65 payments from 10 companies in 2025. Trend: 2023 $1,083 · 2024 $1,403 · 2025 $5,857
Consulting: $3,450Food & beverage: $1,490Travel & lodging: $917
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 29 | $5,049 |
| ViiV Healthcare Company | 18 | $490 |
| Lilly USA, LLC | 4 | $73 |
| Merck Sharp & Dohme LLC | 4 | $63 |
| PFIZER INC. | 3 | $53 |
| Novo Nordisk Inc | 2 | $40 |
| ABBVIE INC. | 2 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| EMD Serono, Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: Yeztugo, DOVATO, MOUNJARO, PIFELTRO, CABENUVA, NURTEC ODT, APRETUDE, MAVYRET.
Industry payments across NY — which companies pay providers there.
